GHK-Cu (Copper Tripeptide) Originally discovered in human plasma, GHK-Cu promotes collagen and elastin synthesis, supports DNA repair, and exhibits strong antioxidant effects
Ongoing safety data supports GLP-1 use for extended periods, with many patients benefiting from 2+ years of continuous therapy without serious adverse effects
Evidence supports that prediabetes is not simply a state of pre-diagnosis as both microvascular and macrovascular complications occur in patients with prediabetes even without the transition to diabetes mellitus [24]
Similarly, FTO and MC4R gene variants affect baseline hunger regulation and energy storage, independent of medication
Both formulations are administered as once-weekly SC injections due to the long half-life of Semaglutide (approximately one week)
Ozempic body changes: Both drugs induce weight loss and body fat redistribution